FLGT FY 2021 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

FY 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$993M+135.4% YoY

Gross Profit

$777M78.3% margin

Operating Income

$676M68.1% margin

Net Income

$507M51.1% margin

EPS (Diluted)

$16.26

Cash Flow

Operating Cash Flow

$539M

Free Cash Flow

$515M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$113M

Stockholders' Equity

$1.2B

Cash & Equivalents

$165M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$993M	$422M	+135.4%
Gross Profit	$777M	$332M	+134.1%
Operating Income	$676M	$290M	+133.0%
Net Income	$507M	$214M	+136.7%